A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity

Endpoint: To assess early urinary (GU) and rectal (GI) toxicities after helical tomotherapy Stereotactic body radiation therapy (SBRT), and to determine their predictive factors. Methods: Since May 2012, 45 prostate cancer patients were treated with eight fractions of 5.48 (low risk, 29%) or 5.65 Gy...

Descripción completa

Detalles Bibliográficos
Autores principales: Macias, Victor A., Blanco, Manuel L., Barrera, Inmaculada, Garcia, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244529/
https://www.ncbi.nlm.nih.gov/pubmed/25505734
http://dx.doi.org/10.3389/fonc.2014.00336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244529/
https://www.ncbi.nlm.nih.gov/pubmed/25505734
http://dx.doi.org/10.3389/fonc.2014.00336

Ejemplares similares